A detailed history of Compass Ion Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Compass Ion Advisors, LLC holds 15,618 shares of PFE stock, worth $411,690. This represents 0.06% of its overall portfolio holdings.

Number of Shares
15,618
Previous 15,214 2.66%
Holding current value
$411,690
Previous $425,000 6.12%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $11,190 - $12,681
404 Added 2.66%
15,618 $451,000
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $9,242 - $10,613
-357 Reduced 2.29%
15,214 $422,000
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $17,794 - $23,113
-681 Reduced 4.19%
15,571 $448,000
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $521,526 - $609,612
16,252 New
16,252 $539,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Compass Ion Advisors, LLC Portfolio

Follow Compass Ion Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Ion Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Ion Advisors, LLC with notifications on news.